CG Oncology CGON Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $33.7M-18.7% | $32.49M-87.4% | $45.15M+4.0% | $14.62M-41.9% | $41.47M-46.5% | ||
| $1.04B+61.1% | $709.67M+46.3% | $635.12M+27.7% | $646.43M+22.5% | $646.96M+32.3% | ||
| $1.28M+270% | $688K-11.9% | $515K+276% | $562K+209% | $345K+125% | ||
| $1.49M— | $1.57M— | $1.5M— | —— | —— | ||
| $23.13M+86.4% | $15.07M+23.4% | $13.51M+20.3% | $11.42M+5.7% | $12.41M+3.9% | ||
| $1.1B+57.2% | $759.48M+0.7% | $695.79M+26.0% | $673.03M+19.4% | $701.19M+21.2% | ||
| $15.07M+5,610% | $15.6M+5,634% | $15.33M+24,232% | $253K+201% | $264K+243% | ||
| $4.51M+337% | $3.97M+1,697% | $4.2M+1,428% | $965K+193% | $1.03M+181% | ||
| $10.3M— | $10.3M— | $10.3M— | —— | —— | ||
| $560K— | $575K— | $1.67M— | —— | —— | ||
| $2.68M-89.4% | $1.68M+1,685% | $114K+115% | $26.68M+50,230% | $25.18M+47,402% | ||
| $1.14B+55.9% | $791.59M+4.9% | $729.91M+32.1% | $701.45M+24.3% | $728.18M+25.7% | ||
| $8.24M+22.4% | $5.71M-12.3% | $9.19M+126% | $7.13M+58.7% | $6.73M+44.5% | ||
| $25.91M+65.5% | $24.21M+65.1% | $20.42M+80.3% | $22.97M+222% | $15.66M+207% | ||
| $1.07M+318% | $915K+392% | $912K+305% | $288K+21.5% | $255K+15.9% | ||
| $35.22M+55.5% | $30.84M+44.3% | $30.53M+95.3% | $30.38M+156% | $22.64M+127% | ||
| $3M— | $3M— | $3M— | —— | —— | ||
| $3.51M+349% | $3.11M+5,873% | $3.33M+4,589% | $706K+498% | $781K+324% | ||
| $4.58M+342% | $4.02M+1,589% | $4.24M+1,333% | $994K+180% | $1.04M+156% | ||
| $1.45M— | $1.74M— | $3.8M— | —— | —— | ||
| $43.48M+85.6% | $38.99M+82.0% | $42.27M+169% | $31.09M+160% | $23.42M+130% | ||
| $9K+12.5% | $8K0.0% | $8K+14.3% | $8K+14.3% | $8K+14.3% | ||
| $1.53B+59.9% | $1.13B+18.9% | $1.03B+41.8% | $964.21M+34.3% | $957.18M+33.7% | ||
| -$439.18M-74.0% | -$378.98M-73.9% | -$337.67M-81.4% | -$293.86M-77.3% | -$252.43M-71.9% | ||
| $1.09B+54.9% | $752.6M+2.6% | $687.64M+28.1% | $670.36M+21.4% | $704.76M+23.9% | ||
| $1.14B+55.9% | $791.59M+4.9% | $729.91M+32.1% | $701.45M+24.3% | $728.18M+25.7% | ||
| $1.04B+61.1% | $709.67M+46.3% | $635.12M+27.7% | $646.43M+22.5% | $646.96M+32.3% | ||
| $2.68M+419% | $1.68M+1,685% | $114K+115% | $522K+885% | $516K+874% | ||
| $4.51M+337% | $3.97M+1,697% | $4.2M+1,428% | $965K+193% | $1.03M+181% | ||
| $560K— | $575K— | $1.67M— | —— | —— | ||
| $4.51M+337% | $3.97M+1,697% | $4.2M+1,428% | $965K+193% | $1.03M+181% | ||
| $2.68M+419% | $1.68M+1,685% | $114K+115% | $522K+885% | $516K+874% | ||
| $4.51M+337% | $3.97M+1,697% | $4.2M+1,428% | $965K+193% | $1.03M+181% | ||
| $2.68M+419% | $1.68M+1,685% | $114K+115% | $522K+885% | $516K+874% | ||
| $307K— | $307K— | $1.61M— | —— | —— | ||
| $25.91M+65.5% | $24.21M+65.1% | $20.42M+80.3% | $22.97M+222% | $15.66M+207% | ||
| $7.58M+631% | $7.02M+2,850% | $7.24M+2,346% | $994K+180% | $1.04M+156% | ||
| $9K+12.5% | $8K0.0% | $8K+14.3% | $8K+14.3% | $8K+14.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can CG Oncology cover its short-term obligations?
- Its current ratio is 31.30 — current assets exceed current liabilities.
- Where does CG Oncology's balance sheet data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.